Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2008

Open Access 01-12-2008 | Research

Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting

Authors: Achim Seeger, Ulrich Kramer, Michael Fenchel, Florian Grimm, Christiane Bretschneider, Jörg Döring, Bernhard Klumpp, Gunnar Tepe, Kilian Rittig, Peter R Seidensticker, Claus D Claussen, Stephan Miller

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2008

Login to get access

Abstract

Background

Previous experiences of whole body MR angiography are predominantly available in linear 0.5 M gadolinium-containing contrast agents. The aim of this study was to compare image quality on a four-point scale (range 1–4) and diagnostic accuracy of a 1.0 M macrocyclic contrast agent (gadobutrol, n = 80 patients) with a 0.5 M linear contrast agent (gadopentetate dimeglumine, n = 85 patients) on a 1.5 T whole body MR system. Digital subtraction angiography served as standard of reference.

Results

All examinations yielded diagnostic image quality. There was no significant difference in image quality (3.76 ± 0.3 versus 3.78 ± 0.3, p = n.s.) and diagnostic accuracy observed. Sensitivity and specificity of the detection of hemodynamically relevant stenoses was 93%/95% in the gadopentetate dimeglumine group and 94%/94% in the gadobutrol group, respectively.

Conclusion

The high diagnostic accuracy of gadobutrol in the clinical routine setting is of high interest as medical authorities (e.g. the European Agency for the Evaluation of Medicinal Products) recommend macrocyclic contrast agents especially to be used in patients with renal failure or dialysis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRefPubMed Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRefPubMed
2.
go back to reference Fenchel M, Requardt M, Tomaschko K, Kramer U, Stauder NI, Naegele T, Schlemmer HP, Claussen CD, Miller S: Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn ResonImaging. 2005, 21: 596-603. 10.1002/jmri.20303. Fenchel M, Requardt M, Tomaschko K, Kramer U, Stauder NI, Naegele T, Schlemmer HP, Claussen CD, Miller S: Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn ResonImaging. 2005, 21: 596-603. 10.1002/jmri.20303.
3.
go back to reference Goyen M, Herborn CU, Kroger K, Ruehm SG, Debatin JF: Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol. 2006, 16 (3): 685-691. 10.1007/s00330-005-0001-8.CrossRefPubMed Goyen M, Herborn CU, Kroger K, Ruehm SG, Debatin JF: Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol. 2006, 16 (3): 685-691. 10.1007/s00330-005-0001-8.CrossRefPubMed
4.
go back to reference Kramer H, Schoenberg SO, Nikolaou K, Huber A, Struwe A, Winnik E, Wintersperger BJ, Dietrich O, Kiefer B, Reiser MF: Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005, 236: 300-310. 10.1148/radiol.2361040609.CrossRefPubMed Kramer H, Schoenberg SO, Nikolaou K, Huber A, Struwe A, Winnik E, Wintersperger BJ, Dietrich O, Kiefer B, Reiser MF: Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005, 236: 300-310. 10.1148/radiol.2361040609.CrossRefPubMed
5.
go back to reference Lin J, Chen B, Wang JH, Zeng MS, Wang YX: Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels. 2006, 21: 395-398. 10.1007/s00380-006-0918-0.CrossRefPubMed Lin J, Chen B, Wang JH, Zeng MS, Wang YX: Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels. 2006, 21: 395-398. 10.1007/s00380-006-0918-0.CrossRefPubMed
6.
go back to reference Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA: Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR AmJ Roentgenol. 2007, 188: 586-592. 10.2214/AJR.06.1094.CrossRef Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA: Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR AmJ Roentgenol. 2007, 188: 586-592. 10.2214/AJR.06.1094.CrossRef
7.
go back to reference Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A: Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007, 243: 148-157. 10.1148/radiol.2431062144.CrossRefPubMed Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A: Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007, 243: 148-157. 10.1148/radiol.2431062144.CrossRefPubMed
9.
go back to reference Goyen M, Herborn CU, Vogt FM, Kroger K, Verhagen R, Yang F, Bosk S, Debatin JF, Ruehm SG: Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn ResonImaging. 2003, 17: 565-571. 10.1002/jmri.10302. Goyen M, Herborn CU, Vogt FM, Kroger K, Verhagen R, Yang F, Bosk S, Debatin JF, Ruehm SG: Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn ResonImaging. 2003, 17: 565-571. 10.1002/jmri.10302.
10.
go back to reference Herborn CU, Goyen M, Quick HH, Bosk S, Massing S, Kroeger K, Stoesser D, Ruehm SG, Debatin JF: Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol. 2004, 182 (6): 1427-1434.CrossRefPubMed Herborn CU, Goyen M, Quick HH, Bosk S, Massing S, Kroeger K, Stoesser D, Ruehm SG, Debatin JF: Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol. 2004, 182 (6): 1427-1434.CrossRefPubMed
11.
go back to reference Fenchel M, Scheule AM, Stauder NI, Kramer U, Tomaschko K, Nagele T, Bretschneider C, Schlemmer HP, Claussen CD, Miller S: Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology–initial clinical results. Radiology. 2006, 238: 280-291. 10.1148/radiol.2381041532.CrossRefPubMed Fenchel M, Scheule AM, Stauder NI, Kramer U, Tomaschko K, Nagele T, Bretschneider C, Schlemmer HP, Claussen CD, Miller S: Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology–initial clinical results. Radiology. 2006, 238: 280-291. 10.1148/radiol.2381041532.CrossRefPubMed
12.
go back to reference Klessen C, Asbach P, Hein PA, Lembcke A, Bauknecht HC, Huppertz A, Nentwig T, Hamm B, Taupitz M: [Whole-body MR angiography: comparison of two protocols for contrast media injection]. Rofo. 2006, 178: 484-490.CrossRefPubMed Klessen C, Asbach P, Hein PA, Lembcke A, Bauknecht HC, Huppertz A, Nentwig T, Hamm B, Taupitz M: [Whole-body MR angiography: comparison of two protocols for contrast media injection]. Rofo. 2006, 178: 484-490.CrossRefPubMed
13.
go back to reference Schaefer FK, Schaefer PJ, Altjohann C, Bourne M, Decobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, et al: A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. EurJ Radiol. 2007, 61: 315-323. 10.1016/j.ejrad.2006.09.002.CrossRef Schaefer FK, Schaefer PJ, Altjohann C, Bourne M, Decobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, et al: A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. EurJ Radiol. 2007, 61: 315-323. 10.1016/j.ejrad.2006.09.002.CrossRef
14.
go back to reference Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG: 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn ResonImaging. 2001, 14: 602-607. 10.1002/jmri.1225. Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG: 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn ResonImaging. 2001, 14: 602-607. 10.1002/jmri.1225.
15.
go back to reference Tombach B, Benner T, Reimer P, Schuierer G, Fallenberg EM, Geens V, Wels T, Sorensen AG: Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. Radiology. 2003, 226: 880-888. 10.1148/radiol.2263011970.CrossRefPubMed Tombach B, Benner T, Reimer P, Schuierer G, Fallenberg EM, Geens V, Wels T, Sorensen AG: Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. Radiology. 2003, 226: 880-888. 10.1148/radiol.2263011970.CrossRefPubMed
16.
go back to reference Fink C, Puderbach M, Ley S, Risse F, Kuder TA, Bock M, Thaler J, Plathow C, Kauczor HU: Intraindividual comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso. J Magn ResonImaging. 2005, 22: 286-290. 10.1002/jmri.20381. Fink C, Puderbach M, Ley S, Risse F, Kuder TA, Bock M, Thaler J, Plathow C, Kauczor HU: Intraindividual comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso. J Magn ResonImaging. 2005, 22: 286-290. 10.1002/jmri.20381.
17.
go back to reference Fink C, Puderbach M, Ley S, Plathow C, Bock M, Zuna I, Kauczor HU: Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Invest Radiol. 2004, 39: 143-148. 10.1097/01.rli.0000101482.79137.f4.CrossRefPubMed Fink C, Puderbach M, Ley S, Plathow C, Bock M, Zuna I, Kauczor HU: Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Invest Radiol. 2004, 39: 143-148. 10.1097/01.rli.0000101482.79137.f4.CrossRefPubMed
18.
go back to reference Fink C, Bock M, Kiessling F, Lichy MP, Krissak R, Zuna I, Schmahl A, Delorme S, Kauczor HU: Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine. J Magn ResonImaging. 2004, 19: 202-208. 10.1002/jmri.10452. Fink C, Bock M, Kiessling F, Lichy MP, Krissak R, Zuna I, Schmahl A, Delorme S, Kauczor HU: Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine. J Magn ResonImaging. 2004, 19: 202-208. 10.1002/jmri.10452.
19.
go back to reference Zhang H, Ho B, Mohajer K, Xu HJ: Peripheral magnetic resonance angiography with a multi-compartment curved leg wrap for thigh compression. J Cardiovasc Magn Reson. 2007, 9: 659-64. 10.1080/10976640601105622.CrossRefPubMed Zhang H, Ho B, Mohajer K, Xu HJ: Peripheral magnetic resonance angiography with a multi-compartment curved leg wrap for thigh compression. J Cardiovasc Magn Reson. 2007, 9: 659-64. 10.1080/10976640601105622.CrossRefPubMed
20.
go back to reference Chiowanich P, Mitchell DG, Ortega HV, Mohamed F: Arterial pseudostenosis on first-pass gadolinium-enhanced three-dimensional MR angiography: new observation of a potential pitfall. AJR Am J Roentgenol. 2000, 175 (2): 523-527.CrossRefPubMed Chiowanich P, Mitchell DG, Ortega HV, Mohamed F: Arterial pseudostenosis on first-pass gadolinium-enhanced three-dimensional MR angiography: new observation of a potential pitfall. AJR Am J Roentgenol. 2000, 175 (2): 523-527.CrossRefPubMed
21.
go back to reference Tombach B, Bremer C, Reimer P, Schaefer RM, Ebert W, Geens V, Heindel W: Pharmacokinetics of 1 M gadobutrol in patients with chronic renal failure. Invest Radiol. 2000, 35: 35-40. 10.1097/00004424-200001000-00004.CrossRefPubMed Tombach B, Bremer C, Reimer P, Schaefer RM, Ebert W, Geens V, Heindel W: Pharmacokinetics of 1 M gadobutrol in patients with chronic renal failure. Invest Radiol. 2000, 35: 35-40. 10.1097/00004424-200001000-00004.CrossRefPubMed
22.
go back to reference Tombach B, Bremer C, Reimer P, Kisters K, Schaefer RM, Geens V, Heindel W: Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology. 2001, 218: 651-657.CrossRefPubMed Tombach B, Bremer C, Reimer P, Kisters K, Schaefer RM, Geens V, Heindel W: Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology. 2001, 218: 651-657.CrossRefPubMed
23.
go back to reference Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004, 15 (5): 1307-1315. 10.1097/01.ASN.0000123691.46138.E2.CrossRefPubMed Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004, 15 (5): 1307-1315. 10.1097/01.ASN.0000123691.46138.E2.CrossRefPubMed
24.
go back to reference Reeder SB, Wintersperger BJ, Dietrich O, Lanz T, Greiser A, Reiser MF, Glazer GM, Schoenberg SO: Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn ResonMed. 2005, 54: 748-754. 10.1002/mrm.20636.CrossRef Reeder SB, Wintersperger BJ, Dietrich O, Lanz T, Greiser A, Reiser MF, Glazer GM, Schoenberg SO: Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn ResonMed. 2005, 54: 748-754. 10.1002/mrm.20636.CrossRef
Metadata
Title
Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting
Authors
Achim Seeger
Ulrich Kramer
Michael Fenchel
Florian Grimm
Christiane Bretschneider
Jörg Döring
Bernhard Klumpp
Gunnar Tepe
Kilian Rittig
Peter R Seidensticker
Claus D Claussen
Stephan Miller
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2008
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-10-63

Other articles of this Issue 1/2008

Journal of Cardiovascular Magnetic Resonance 1/2008 Go to the issue